Literature DB >> 7008557

Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.

W R Walker, S J Beveridge, M W Whitehouse.   

Abstract

A review is presented of both published work and unpublished observations concerned with: a) the 'efficacy' of copper bracelets for arthritis; b) the bio-reactivity of metallic copper (especially with human sweat); c) permeation of the skin by Cu(II) when complexed with certain ligands (such as salicylates); d) the pharmacological and clinical activity of AlcusalR and DermcusalR, two formulations of copper salicylate with ethanol and dimethyl sulphoxide respectively that can be applied to the skin. Topical application promises to be a superior alternative to orally ingested drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7008557

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  5 in total

1.  The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats.

Authors:  Z Korolkiewicz; E Hać; I Gagało; P Gorczyca; A Lodzińska
Journal:  Agents Actions       Date:  1989-03

Review 2.  The role of copper in inflammatory disorders.

Authors:  A J Lewis
Journal:  Agents Actions       Date:  1984-12

Review 3.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

4.  Selected Biomarkers Revealed Potential Skin Toxicity Caused by Certain Copper Compounds.

Authors:  Hairui Li; Pei Zhen Toh; Jia Yao Tan; Melvin T Zin; Chi-Ying Lee; Bo Li; Melvina Leolukman; Hongqian Bao; Lifeng Kang
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

5.  Magnet therapy for the relief of pain and inflammation in rheumatoid arthritis (CAMBRA): a randomised placebo-controlled crossover trial.

Authors:  Stewart J Richmond
Journal:  Trials       Date:  2008-09-12       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.